We are live on ! Find out more
EVOK

Evoke Pharma
EVOK

Delisted

EVOK was delisted on the 16th of December, 2025.

Back to rankings

0 hedge funds and large institutions have $0 invested in Evoke Pharma in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

37.9% less ownership

Funds ownership: 37.9% → 0% (-38%)

100% less funds holding

Funds holding: 15 → 0 (-15)

100% less capital invested

Capital invested by funds: $2.94M → $0 (-$2.94M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 15

Holders
–
Holders Change
-15
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$792K
2
NCM
Nantahala Capital Management
Connecticut
-$736K
3
BL
Bleichroeder LP
New York
-$728K
4
NWMG
National Wealth Management Group
Ohio
-$398K
5
DS
DRW Securities
Illinois
-$118K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
– -$792K -159,358 Closed
NCM
2
Nantahala Capital Management
Connecticut
– -$736K -148,153 Closed
BL
3
Bleichroeder LP
New York
– -$728K -146,395 Closed
NWMG
4
National Wealth Management Group
Ohio
– -$398K -80,130 Closed
DS
5
DRW Securities
Illinois
– -$118K -23,742 Closed
Vanguard Group
6
Vanguard Group
Pennsylvania
– -$93.2K -18,759 Closed
TSS
7
Two Sigma Securities
New York
– -$51.9K -10,437 Closed
Osaic Holdings
8
Osaic Holdings
Arizona
– -$16.4K -3,010 Closed
Northwestern Mutual Wealth Management
9
Northwestern Mutual Wealth Management
Wisconsin
– -$1.35K -272 Closed
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
– -$1K -190 Closed
BlackRock
11
BlackRock
New York
– -$606 -122 Closed
SS
12
SBI Securities
Japan
– -$378 -76 Closed
TRCT
13
Tower Research Capital (TRC)
New York
– -$199 -40 Closed
NA
14
NewEdge Advisors
Louisiana
– -$84 -17 Closed
Bank of America
15
Bank of America
North Carolina
– -$60 -12 Closed

EVOK Hedge Fund Activity: Q4 2025 in Review

0 of the 8,245 institutional investors tracked by Wall St. Rank reported a position in Evoke Pharma (EVOK) for Q4 2025, worth a combined $0 — down 100% from $2.94M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of EVOK and 0 opened new positions — a net loss of 15 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Morgan Stanley, exiting entirely with an estimated $792K sold.

  • 0 institutional investors held Evoke Pharma (EVOK) as of Q4 2025, down from 15 in Q3 2025.
  • Funds reported $0 of Evoke Pharma stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Evoke Pharma positions in Q4 2025 and 15 closed out, a net change of -15 holders.
  • The largest Evoke Pharma seller in Q4 2025 was Morgan Stanley, an estimated $792K sold.

Based on aggregated 13F filings for Q4 2025.